Loading…
Preparing for All Hazards and Pathogens Reauthorization Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
72pct
19d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (56)
Ordered to be Reported (Amended) by the Yeas and Nays: 28 - 23.
Committee Consideration and Mark-up Session Held.
Subcommittee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 17 - 11.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to dialysis. Issues regarding the pharmaceutical supply chain. Issues concerning drug shortages. Monitored issues concerning sterilization of medical devices. S. 2333, Pandemic and All-Hazards Preparedness and Response Act (PAHPA). H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. Issues concerning Hurricane Helene. H.R. 10545, American Relief Act, 2025 and H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 and issues related to PAHPA and access to IV Solutions.
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Infectious diseases (generally, no specific legislation); antimicrobial (generally, no specific legislation); hospital-acquired infections (generally, no specific legislation); immunizations (generally, no specific legislation); pandemic influenza (generally, no specific legislation); public health security and bio-defense (generally, no specific legislation); global infectious diseases (generally, no specific legislation); biomedical research (generally, no specific legislation); President's Emergency Plan for AIDS Relief (PEPFAR) (generally, no specific legislation); Lyme diseases and other infectious diseases issues (generally, no specific legislation); Ryan White Care Act (generally, no specific legislation); Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR);HIV Epidemic Loan Repayment Program (HELP) Act(H.R. 2295) Verifying Accurate Leading Edge IVCT Development (VALID Act HR 3128/S.2209), Infectious diseases and bio-preparedness health professionals loan repayment issues, BIO Preparedness Workforce Act (S.3244/H.R.5602), Monkeypox outbreak and response (generally, no specific information), PHE Outbreak Activation Act (not-yet introduced), PREVENT Pandemics Act, Preparing for All Hazards and Pathogens Reauthorization Act (HR 4421), Pandemics and All-Hazards Preparedness and Response Act (S.2333), ID incentive payments (no specific information or bill numbers), CMS Medicare Physician Fee Schedule, avian flu (generally, no specific bill)
Client expense: $247,000 · Firm income: Not reported
2024 · fourth_quarter · Health Issues
Infectious diseases (generally, no specific legislation); antimicrobial (generally, no specific legislation); hospital-acquired infections (generally, no specific legislation); immunizations (generally, no specific legislation); pandemic influenza (generally, no specific legislation); public health security and bio-defense (generally, no specific legislation); global infectious diseases (generally, no specific legislation); biomedical research (generally, no specific legislation); President's Emergency Plan for AIDS Relief (PEPFAR) (generally, no specific legislation); Lyme diseases and other infectious diseases issues (generally, no specific legislation); Ryan White Care Act (generally, no specific legislation); Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR);HIV Epidemic Loan Repayment Program (HELP) Act(H.R. 2295) Verifying Accurate Leading Edge IVCT Development (VALID Act HR 3128/S.2209), Infectious diseases and bio-preparedness health professionals loan repayment issues, BIO Preparedness Workforce Act (S.3244/H.R.5602), Monkeypox outbreak and response (generally, no specific information), PHE Outbreak Activation Act (not-yet introduced), PREVENT Pandemics Act, Preparing for All Hazards and Pathogens Reauthorization Act (HR 4421), Pandemics and All-Hazards Preparedness and Response Act (S.2333), ID incentive payments (no specific information or bill numbers), CMS Medicare Physician Fee Schedule, avian flu outbreak (generally, no specific bill)
Client expense: $255,000 · Firm income: Not reported
2024 · fourth_quarter · Health Issues
Legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421). American Relief Act (P.L. 118-158).
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| HR 3837 |
118th |
| Related bill |
| HR 3832 | 118th | Related bill |
| HR 3795 | 118th | Related bill |
| HR 3703 | 118th | Related bill |
| HR 3613 | 118th | Related bill |
| HR 2416 | 118th | Related bill |
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2024 · fourth_quarter · Health Issues
Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals including Strategic National Stockpile appropriations and reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act; S.2624/HR 5894, Fiscal Year 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
Monitored S. 2333, Pandemic and All-Hazards Preparedness and Response Act regarding PAHPA reauthorization. Monitored H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act. H.R. 10445, Furthering Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. S. 2840, Bipartisan Primary Care and Health Workforce Act, as it relates to hospitals and the healthcare workforce. Monitored issues related to the World Trade Center Health Program. Monitored issues regarding ARPA-H. Issues involving drug shortages. Issues regarding NIH reform. Issues related to hurricane response.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 456: Fairness in Orphan Drug Exclusivity Act H.R. 766: Dr. Michael C. Burgess Preventive Health Savings Act H.R. 830: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1613: Drug Price Transparency in Medicaid Act of 2023 H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2534: PROTECT 340B Act of 2023 - Provisions related to the 340B program H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 2707: MADE in America Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3433: Give Kids a Chance Act of 2024 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3839: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act H.R. 4818: Treat and Reduce Obesity Act of 2023 H.R. 4895: Lowering Drug Costs for American Families Act - Provisions related to drug pricing H.R. 4988: Modern Authentication of Pharmaceuticals Act of 2023 H.R. 5376: Share the Savings with Seniors Act H.R. 5378: Lower Costs, More Transparency Act H.R. 5391: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 5539: ORPHAN Cures Act H.R. 6283: Delinking Revenue from Unfair Gouging or DRUG Act H.R. 6664: Innovation in Pediatric Drugs Act of 2023 H.R. 7024 Tax Relief for American Families and Workers Act of 2024 H.R. 7174: Ensuring Pathways to Innovative Cures (EPIC) Act: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7248: FDA Modernization Act 3.0 H.R. 7623: Telehealth Modernization Act of 2024 H.R. 7635: The 340B PATIENTS Act of 2024 H.R. 8574: 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act H.R. 9096: Pharmacists Fight Back Act S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1130: Health Care PRICE Transparency Act S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 1589: Safeguarding Patients and Taxpayers Act S. 1967: PBM Act S. 2305: Biosimilar Red Tape Elimination Act S. 2333: Pandemic and All-Hazards Preparedness and Response Act S. 2474: Share the Savings with Seniors Act S. 2477: Equitable Community Access to Pharmacist Services Act S. 2973: Modernizing and Ensuring PBM Accountability Act (MEPA) S. 3393: SUPPORT for Patients and Communities Reauthorization Act S. 3430: Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 S. 5021: 340B PATIENTS Act of 2024 S. 5040: Protecting Patients from Deceptive Drugs Online Act S. 5459: Biosimilars Access and Affordability Act BioCompete Act (draft) Executive Order of February 28, 2024, Preventing Access to Americans' Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) User fee policy issues Inflation Reduction Act of 2022 (P.L. 117-169) IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Supply chain policy issues Clinical trial diversity policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Pandemic preparedness policy issues Artificial intelligence policy issues Vaccine provisions of the Inflation Reduction Act Policy issues related to vaccines
Client expense: $920,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2024 · fourth_quarter · Health Issues
Lobbying Issues Description: Budget and appropriations for public health, disease and injury prevention, including obesity and related diseases; pandemics and emerging infectious diseases; physical activity; public health preparedness; nutrition programs; environmental health; health equity; community-based public health interventions; public health infrastructure and workforce; and substance misuse/behavioral health issues. Specific Legislation: 1.Preventing Adverse Childhood Experiences Act (S. 3085) 2.Mental Health Services for Students Act (S. 1884/H.R. 3713) 3.Helping Kids Cope Act (H.R. 2412) 4.Advancing Student Services in Schools Today Act (S. 1774/H.R. 3761) 5.Student Mental Health Rights Act (H.R. 3726) 6.Pursuing Equity in Mental Health Act (S. 1700/H.R. 3548) 7.RISE from Trauma Act (S. 1426) 8.Better Mental Health Care for Americans Act (S. 923) 9.Reentry Act (S. 1165/H.R. 2400) 10.FY 2024 Labor, HHS, Education and Related Agencies Appropriations 11.FY 2025 Labor, HHS, Education and Related Agencies Appropriations 12.Farm Bill 13.Improving Social Determinants of Health Act (H.R. 4781/S. 3847) 14.Health Equity and Accountability Act of 2024 (H.R. 9161/S.4773) 15.Social Determinants Accelerator Act (S.5474) 16.The UNDERSTAND Act (S. 5182) 17.SNAP Nutrition Security Act of 2023 (S.2326/ H.R.4909) 18.SWEET Act (Not yet introduced) 19.OH SNAP, Close the Fruit and Vegetable Gap Act of 2023 (S. 2015/ H.R. 4149) 20.FY 2026 Labor, HHS, Education and Related Agencies Appropriations 21.The TRUTH in Labeling Act (H.R.6766/ S.3512) 22.Personal Health Investment Today (PHIT) Act (Not yet introduced) 23.Child Nutrition Reauthorization 24.Whole Milk for Healthy Kids Act of 2023 (H.R. 1147/ S. 1957) 25.Promoting Physical Activity for Americans Act (S.397) 26.CDC Oral Health Reauthorization Act (Not yet introduced) 27.GusNIP Expansion Act of 2023 (H.R. 4856) 28.Senior Hunger Prevention Act of 2023 (S. 1036/ H.R. 3474) 29.Black Maternal Health Momnibus Act (H.R. 3305/S. 1606) 30.Older Americans Act (Not yet introduced) 31.Protecting the Health of Americas Older Adults Act (Not yet introduced) 32.REAADI Act (S. 1049) 33.Improving Data in Public Health Act (H.R. 3791) 34.Pandemic and All-Hazards Preparedness Act Reauthorization (H.R. 4420, H.R. 4421) 35.Public Health Infrastructure Saves Lives Act (S. 1995) 36.BIO Early Warning Act (Not yet introduced) 37.The Support for Patients and Communities Reauthorization Act (S.2433/H.R. 4531) 38.The PEER Support Act (S. 2733/H.R. 7212) 39.The Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act (S. 1378/ H.R. 5819) 40.The Barriers to Suicide Act (H.R. 3759) 41.The 9-8-8 Implementation Act (H.R. 4851) 42.Influenza Act (H.R. 5846) 43.Bipartisan Primary Care and Health Workforce Act (S. 2840) 44.National Defense Authorization Act (S. 2226) 45.A resolution declaring racism a public health crisis (S. Res 319) 46.Preventing Maternal Deaths Reauthorization Act of 2023 (S. 2415) 47.Continuity in Necessary Evaluative Crisis Treatment (CONNECT) Act (H.R. 6928) 48.Local 988 Response Act (S. 3444) 49.Better Mental Health Care, Lower Drug Cost, and Extenders Act (S. 3430) 50.Lead-Safe Housing for Kids Act (Not yet introduced) 51.The Medicaid Bump Act (S. 3921/H.R. 4892) 52.The Kid PROOF Act (S. 3364/H.R. 6663) 53.EARLY Minds Act (H.R. 7808) 54.Campus Prevention and Recovery Services for Students Act (H.R. 9214) 55.Stabilization to Prevent (STOP) Suicide Act (H.R. 9577) 56.FY 2025 Interior, Environment and Related Agencies Appropriations 57.American Family Act (H.R. 3899) 58.H.Res.1375 - Recognizing the threat of extreme weather to children's health and well-being, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children. House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, White House Domestic Policy Council, HHS, CDC, FDA, CMS, OMB, NIH, USDA, HRSA, SAMHSA, and Federal Communications Commission (FCC).
Client expense: $39,452 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
2024 · fourth_quarter · Health Issues
Issues relating to drug pricing, ESRD reimbursement for Hemodialysis, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic preparedness act. H. Res. 550 and H.R. 4421. Issues related to artificial intelligence technology in healthcare; issues related to Hurricane Helene, and HR 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act 2025.
Client expense: $560,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 456: Fairness in Orphan Drug Exclusivity Act H.R. 830: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1613: Drug Price Transparency in Medicaid Act of 2023 H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2534: PROTECT 340B Act of 2023 - Provisions related to the 340B program H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 2707: MADE in America Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3433: Give Kids a Chance Act of 2024 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3839: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act H.R. 4818: Treat and Reduce Obesity Act of 2023 H.R. 4895: Lowering Drug Costs for American Families Act - Provisions related to drug pricing H.R. 4988: Modern Authentication of Pharmaceuticals Act of 2023 H.R. 5376: Share the Savings with Seniors Act H.R. 5378: Lower Costs, More Transparency Act H.R. 5391: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 5539: ORPHAN Cures Act H.R. 6283: Delinking Revenue from Unfair Gouging or DRUG Act H.R. 6664: Innovation in Pediatric Drugs Act of 2023 H.R. 7174: Ensuring Pathways to Innovative Cures (EPIC) Act: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7248: FDA Modernization Act 3.0 H.R. 7623: Telehealth Modernization Act of 2024 H.R. 7635: The 340B PATIENTS Act of 2024 H.R. 8574: 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act H.R. 9096: Pharmacists Fight Back Act S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1130: Health Care PRICE Transparency Act S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1497: Emergency Access to Insulin Act of 2023 S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 1589: Safeguarding Patients and Taxpayers Act S. 1967: PBM Act S. 2305: Biosimilar Red Tape Elimination Act S. 2333: Pandemic and All-Hazards Preparedness and Response Act S. 2474: Share the Savings with Seniors Act S. 2973: Modernizing and Ensuring PBM Accountability Act S. 3393: SUPPORT for Patients and Communities Reauthorization Act S. 3430: Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 S. 5021: 340B PATIENTS Act of 2024 S. 5040: Protecting Patients from Deceptive Drugs Online Act S. 5459: Biosimilars Access and Affordability Act BioCompete Act (draft) Executive Order of February 28, 2024, Preventing Access to Americans' Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) User fee policy issues Inflation Reduction Act of 2022 (P.L. 117-169) IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Compounding policy issues Antimicrobial resistance (AMR) policy issues Supply chain policy issues Clinical trial diversity policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Pandemic preparedness policy issues Artificial intelligence policy issues
Client expense: $7,560,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008 - Drug Shortage Prevention and Mitigation Act; Issues related to drug shortages.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
S. 2333, Pandemic and All-Hazards Preparedness and Response Act. H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act. Funding for medical countermeasure enterprise including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY2025. Opioid and heroin addiction legislation, naloxone access and awareness.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2024 · fourth_quarter · Health Issues
S. 2840, Bipartisan Primary Care and Health Workforce Act, as it relates to hospitals and the health care workforce. Issues related to behavioral health. Issues related to hospital reimbursement. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to hospitals. Monitored S. 2333, Pandemic and All-Hazards Preparedness and Response Act. Monitored H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act. Monitored SUPPORT Act reauthorization. Issues related to hurricane response. H.R. 10545, American Relief Act of 2025 and issues related to hospitals. H.R. 10445, Furthering Continuing Appropriations and Disaster Relief Supplemental Appropriations Act of 2025 and issues related to hospitals.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40); CMS Physician Fee Schedule CY25 Proposed Rule (RIN #0938-AV33);Continuing appropriations for FY25 (HR 9747, HR 10545)
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2024 · fourth_quarter · Health Issues
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 1692, Health Care Affordability Act of 2023 H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage H.R. 8018, the Alleviating Barriers for Caregivers Act, support passage S. 3109, the Alleviating Barriers for Caregivers Act, support passage H.R.6302, the Health Share Transparency Act of 2023 H.R.7623, the Telehealth Modernization Act of 2024
Client expense: $51,247 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
FY 2024 and 2025 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, and S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; S.4667 - Risky Research Review Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - the Preparing for All Hazards and Pathogens Reauthorization Act); Drug pricing issues; PBM reform (S. 2973 -Modernizing and Ensuring PBM Accountability Act and S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); Rare Pediatric Disease Priority Review Voucher Program reauthorization (H.R. 7384/ S. 4583 - Creating Hope Reauthorization Act); National Vaccine Injury Compensation Program.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to dialysis. Issues regarding the pharmaceutical supply chain. Issues concerning drug shortages. Monitored issues concerning sterilization of medical devices. S. 2333, Pandemic and All-Hazards Preparedness and Response Act (PAHPA). H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. Issues concerning Hurricane Helene. H.R. 10545, American Relief Act, 2025 and H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 and issues related to PAHPA and access to IV Solutions.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Disaster Planning/Emergencies
Access to emergency medical supplies (including Personal Protective Equipment, COVID-19 tests, ventilators, and medications) during COVID-19 public health emergency Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) H.R. 4420, the Preparedness and Response Reauthorization Act H.R. 4421, the Preparing for All Hazards and Pathogens Reauthorization Act S.2333-Pandemic and All-Hazards Preparedness and Response Act
Client expense: $407,855 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Defense
National Defense Authorization Act for 2024, H.R. 2670 Pandemic and All-Hazards Preparedness and Response Act, S. 2333 Preparing for All Hazards and Pathogens Reauthorization Act, H.R. 4421 Further Consolidated Appropriations Act, 2024, H.R. 2882 Other issues related to the Strategic National Stockpile, Biodefense, Preparedness, Biomanufacturing
Client expense: $170,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE
2024 · fourth_quarter · Health Issues
National Defense Authorization Act for 2024, H.R. 2670 Pandemic and All-Hazards Preparedness and Response Act, S. 2333 Preparing for All Hazards and Pathogens Reauthorization Act, H.R. 4421 Further Consolidated Appropriations Act, 2024, H.R. 2882 Other issues related to the Strategic National Stockpile, Biodefense, Preparedness, Biomanufacturing
Client expense: $170,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE
2024 · fourth_quarter · Health Issues
Preparing for All Hazards and Pathogens Reauthorization Act, H.R. 4421 Pandemic and All-Hazards Preparedness and Response Act, S. 2333 Other Biomanufacturing & Preparedness Issues
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Defense
Preparing for All Hazards and Pathogens Reauthorization Act, H.R. 4421 Pandemic and All-Hazards Preparedness and Response Act, S. 2333 Other Biomanufacturing & Preparedness Issues
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333); see also Public Law No: 118-158.
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Issues related to pandemic preparedness and strategic stockpile readiness, including state strategic stockpiles demonstration included in the PREVENT Act. Pandemic and All-Hazards Preparedness Act reauthorization, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, and H.R.10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
H.R.4421/S.2333 - Preparing for All-Hazards Preparedness Act (PAHPA) Reauthorization (issues related to ASPR authorization); S.2624 - Departments of Labor, Health and Human Services, and Education Appropriations Act, 2024 (issues related to Social Security Administration funding).
Client expense: $1,150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage, the transition out of the COVID-19 pandemic and electronic health information/technology. H.R. 4527 Health DATA Act S. 3679, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 5378 the Lower Costs, More Transparency Act S.3548 - Health Care Prices Revealed and Information to Consumers Explained Transparency Act S.3430 - An original bill to amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes. HR 3305 & S. 1606 Black Maternal Health Momnibus Act HR 4822 Health Care Price Transparency Act HR 3284 Providers and Payers COMPETE Act HR 2840 Bipartisan Primary Care and Health Workforce Act HR 4818 Treat and Reduce Obesity Act of 2023 S. 2333 Pandemic and All Hazards Preparedness and Response Act H.R. 4421 Preparing for All Hazards and Pathogens Reauthorization Act H.R. 3561, PATIENT Act of 2023 H.R. 3281, the Transparent PRICE Act H.R. 3262, To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R. 2868 Association Health Plans Act H.R. 2813 Self-Insurance Protection Act H.R. 3799 CHOICE Arrangement Act H.R. 3432, Telemental Health Care Access Act H.R.824, Telehealth Benefit Expansion for Workers Act of 2023 H.R. 4189, S. 2016, CONNECT for Health Act S. 923, Better Mental Health Care for Americans Act H.R. 3120, Healthy Competition for Better Care Act H.R. 1843 Telehealth Expansion Act of 2023 S.954 - 118th Congress (2023-2024)A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals. H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R.10515 - American Relief Act, 2025 H.R.10545 - American Relief Act, 2025 H.R. 9774 & S. 5194 - Health Care Affordability Act of 2024 H.R. 3120 & S. 1451 - Healthy Competition for Better Care Act
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Client expense: Not reported · Firm income: $80,000
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · fourth_quarter · Medicare/Medicaid
S. 2333 - Pandemic and All-Hazards Preparedness and Response Act (PAHPA) H.R. 4420 - The Preparedness and Response Reauthorization Act H.R. 4421 - The Preparing for All Hazards and Pathogens Reauthorization Act H.R. 715/S. 494 - The Bipartisan Background Checks Act/Background Check Expansion Act S. 1140/H.R. 1781 - Ensuring Access to General Surgery Act H.R. 2416 - MISSION Zero Reauthorization S. 220/H.R. 731 - Workforce Mobility Act (Non-compete Legislation) S. 705/H.R. 2761 - The Specialty Physicians Advancing Rural Care (SPARC) Act S. 704/H.R. 1202 - The Resident Education Deferred Interest (REDI) Act S. 1653 - Prevent BLEEDing Act S. 2644 - Law Enforcement Sustaining Aid and Vital Emergency Resources (SAVER) Act H.R. 2474 - Strengthening Medicare for Patients and Providers Act H.R. 5213 - Reducing Medically Unnecessary Delays in Care H.R. 6487/S. 3805 - No Fees for EFTS H.R. 6960/S. 3765 - Emergency Medical Services for Children Act Reauthorization S. 3679/H.R.7153 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. RES. 567 - Resolution for Health Workforce Well-Being Day of Awareness S. 1447 - The Bipartisan Solution to Cyclical Violence Act H.R. 2819 - Good Samaritan Health Professionals Act H.R. 4366 - Consolidated Appropriations Act, 2024 S. 1894/H.R. 3382 - Colorectal Cancer Payment Fairness Act H.R. 3086 - Find it Early Act H.R. 8702/S. 4532 - Improving Seniors Timely Access to Care Act H.R. 7855 - Rural Residency Planning and Development Act S. 2768/H.R. 2584 - Safety from Violence for Healthcare Employees (SAVE) Act H.R.9001 - Physician Led and Rural Access to Quality Care Act S. 4847 - Advancing Medical Readiness Act of 2024 H.R. 10073 - Medicare Patient Access and Practice Stabilization Act Scope of Practice Expansion Episodes of Care/Transforming Episode Accountability Model (TEAM) Physician-Focused Payment Model Technical Advisory Committee (PTAC) reform Telehealth issues MACRA reforms through MIPS e-prescribing Medicare Physician Fee Schedule CMS Quality Payment Program (QPP) Proposed Rule Safe opioid disposal policy Bilateral Exchange Visa Issues/Visas for physician educational and cultural exchange (Conrad-30 Waiver Program) Medicare Price Transparency Labor HHS Appropriations Medicare Physician Payment Cuts AI Taskforce Neglected Surgical Conditions Age Friendly Hospital Measure in IQR program Stop the Bleed program Cancer Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda National Trauma and Emergency Preparedness System (NTEPs) Administrative Burden/Prior Authorization Legislation Physician Burnout and Wellbeing Organ Transplant National Cancer Database (NCDB) updates Merit-based Incentive Payment System (MIPS) and MIPS Value Pathways (MVPs) Health Equity Firearm injury prevention research Global Code data collection Surgeon compensation studies Council on Graduate Medical Education (COGME) rural surgery studies Surgical Hospital Measures
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
S. 2333 - Pandemic and All-Hazards Preparedness and Response Act (PAHPA) H.R. 4420 - The Preparedness and Response Reauthorization Act H.R. 4421 - The Preparing for All Hazards and Pathogens Reauthorization Act H.R. 715/S. 494 - The Bipartisan Background Checks Act/Background Check Expansion Act S. 1140/H.R. 1781 - Ensuring Access to General Surgery Act H.R. 2416 - MISSION Zero Reauthorization S. 220/H.R. 731 - Workforce Mobility Act (Non-compete Legislation) S. 705/H.R. 2761 - The Specialty Physicians Advancing Rural Care (SPARC) Act S. 704/H.R. 1202 - The Resident Education Deferred Interest (REDI) Act S. 1653 - Prevent BLEEDing Act S. 2644 - Law Enforcement Sustaining Aid and Vital Emergency Resources (SAVER) Act H.R. 2474 - Strengthening Medicare for Patients and Providers Act H.R. 5213 - Reducing Medically Unnecessary Delays in Care H.R. 6487/S. 3805 - No Fees for EFTS H.R. 6960/S. 3765 - Emergency Medical Services for Children Act Reauthorization S. 3679/H.R.7153 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. RES. 567 - Resolution for Health Workforce Well-Being Day of Awareness S. 1447 - The Bipartisan Solution to Cyclical Violence Act H.R. 2819 - Good Samaritan Health Professionals Act H.R. 4366 - Consolidated Appropriations Act, 2024 S. 1894/H.R. 3382 - Colorectal Cancer Payment Fairness Act H.R. 3086 - Find it Early Act H.R. 8702/S. 4532 - Improving Seniors Timely Access to Care Act H.R. 7855 - Rural Residency Planning and Development Act S. 2768/H.R. 2584 - Safety from Violence for Healthcare Employees (SAVE) Act H.R.9001 - Physician Led and Rural Access to Quality Care Act S. 4847 - Advancing Medical Readiness Act of 2024 H.R. 10073 - Medicare Patient Access and Practice Stabilization Act Scope of Practice Expansion Episodes of Care/Transforming Episode Accountability Model (TEAM) Physician-Focused Payment Model Technical Advisory Committee (PTAC) reform Telehealth issues MACRA reforms through MIPS e-prescribing Medicare Physician Fee Schedule CMS Quality Payment Program (QPP) Proposed Rule Safe opioid disposal policy Bilateral Exchange Visa Issues/Visas for physician educational and cultural exchange (Conrad-30 Waiver Program) Medicare Price Transparency Labor HHS Appropriations Medicare Physician Payment Cuts AI Taskforce Neglected Surgical Conditions Age Friendly Hospital Measure in IQR program Stop the Bleed program Cancer Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda National Trauma and Emergency Preparedness System (NTEPs) Administrative Burden/Prior Authorization Legislation Physician Burnout and Wellbeing Organ Transplant National Cancer Database (NCDB) updates Merit-based Incentive Payment System (MIPS) and MIPS Value Pathways (MVPs) Health Equity Firearm injury prevention research Global Code data collection Surgeon compensation studies Council on Graduate Medical Education (COGME) rural surgery studies Surgical Hospital Measures
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
S. 2333 - Pandemic and All-Hazards Preparedness and Response Act (PAHPA) H.R. 4420 - The Preparedness and Response Reauthorization Act H.R. 4421 - The Preparing for All Hazards and Pathogens Reauthorization Act H.R. 715/S. 494 - The Bipartisan Background Checks Act/Background Check Expansion Act S. 1140/H.R. 1781 - Ensuring Access to General Surgery Act H.R. 2416 - MISSION Zero Reauthorization S. 220/H.R. 731 - Workforce Mobility Act (Non-compete Legislation) S. 705/H.R. 2761 - The Specialty Physicians Advancing Rural Care (SPARC) Act S. 704/H.R. 1202 - The Resident Education Deferred Interest (REDI) Act S. 1653 - Prevent BLEEDing Act S. 2644 - Law Enforcement Sustaining Aid and Vital Emergency Resources (SAVER) Act H.R. 2474 - Strengthening Medicare for Patients and Providers Act H.R. 5213 - Reducing Medically Unnecessary Delays in Care H.R. 6487/S. 3805 - No Fees for EFTS H.R. 6960/S. 3765 - Emergency Medical Services for Children Act Reauthorization S. 3679/H.R.7153 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. RES. 567 - Resolution for Health Workforce Well-Being Day of Awareness S. 1447 - The Bipartisan Solution to Cyclical Violence Act H.R. 2819 - Good Samaritan Health Professionals Act H.R. 4366 - Consolidated Appropriations Act, 2024 S. 1894/H.R. 3382 - Colorectal Cancer Payment Fairness Act H.R. 3086 - Find it Early Act H.R. 8702/S. 4532 - Improving Seniors Timely Access to Care Act H.R. 7855 - Rural Residency Planning and Development Act S. 2768/H.R. 2584 - Safety from Violence for Healthcare Employees (SAVE) Act H.R.9001 - Physician Led and Rural Access to Quality Care Act S. 4847 - Advancing Medical Readiness Act of 2024 H.R. 10073 - Medicare Patient Access and Practice Stabilization Act Scope of Practice Expansion Episodes of Care/Transforming Episode Accountability Model (TEAM) Physician-Focused Payment Model Technical Advisory Committee (PTAC) reform Telehealth issues MACRA reforms through MIPS e-prescribing Medicare Physician Fee Schedule CMS Quality Payment Program (QPP) Proposed Rule Safe opioid disposal policy Bilateral Exchange Visa Issues/Visas for physician educational and cultural exchange (Conrad-30 Waiver Program) Medicare Price Transparency Labor HHS Appropriations Medicare Physician Payment Cuts AI Taskforce Neglected Surgical Conditions Age Friendly Hospital Measure in IQR program Stop the Bleed program Cancer Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda National Trauma and Emergency Preparedness System (NTEPs) Administrative Burden/Prior Authorization Legislation Physician Burnout and Wellbeing Organ Transplant National Cancer Database (NCDB) updates Merit-based Incentive Payment System (MIPS) and MIPS Value Pathways (MVPs) Health Equity Firearm injury prevention research Global Code data collection Surgeon compensation studies Council on Graduate Medical Education (COGME) rural surgery studies Surgical Hospital Measures
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Medicare/Medicaid
S. 2333 - Pandemic and All-Hazards Preparedness and Response Act (PAHPA) H.R. 4420 - The Preparedness and Response Reauthorization Act H.R. 4421 - The Preparing for All Hazards and Pathogens Reauthorization Act H.R. 715/S. 494 - The Bipartisan Background Checks Act/Background Check Expansion Act S. 1140/H.R. 1781 - Ensuring Access to General Surgery Act H.R. 2416 - MISSION Zero Reauthorization S. 220/H.R. 731 - Workforce Mobility Act (Non-compete Legislation) S. 705/H.R. 2761 - The Specialty Physicians Advancing Rural Care (SPARC) Act S. 704/H.R. 1202 - The Resident Education Deferred Interest (REDI) Act S. 1653 - Prevent BLEEDing Act S. 2644 - Law Enforcement Sustaining Aid and Vital Emergency Resources (SAVER) Act H.R. 2474 - Strengthening Medicare for Patients and Providers Act H.R. 5213 - Reducing Medically Unnecessary Delays in Care H.R. 6487/S. 3805 - No Fees for EFTS H.R. 6960/S. 3765 - Emergency Medical Services for Children Act Reauthorization S. 3679/H.R.7153 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. RES. 567 - Resolution for Health Workforce Well-Being Day of Awareness S. 1447 - The Bipartisan Solution to Cyclical Violence Act H.R. 2819 - Good Samaritan Health Professionals Act H.R. 4366 - Consolidated Appropriations Act, 2024 S. 1894/H.R. 3382 - Colorectal Cancer Payment Fairness Act H.R. 3086 - Find it Early Act H.R. 8702/S. 4532 - Improving Seniors Timely Access to Care Act H.R. 7855 - Rural Residency Planning and Development Act S. 2768/H.R. 2584 - Safety from Violence for Healthcare Employees (SAVE) Act H.R.9001 - Physician Led and Rural Access to Quality Care Act S. 4847 - Advancing Medical Readiness Act of 2024 H.R. 10073 - Medicare Patient Access and Practice Stabilization Act Scope of Practice Expansion Episodes of Care/Transforming Episode Accountability Model (TEAM) Physician-Focused Payment Model Technical Advisory Committee (PTAC) reform Telehealth issues MACRA reforms through MIPS e-prescribing Medicare Physician Fee Schedule CMS Quality Payment Program (QPP) Proposed Rule Safe opioid disposal policy Bilateral Exchange Visa Issues/Visas for physician educational and cultural exchange (Conrad-30 Waiver Program) Medicare Price Transparency Labor HHS Appropriations Medicare Physician Payment Cuts AI Taskforce Neglected Surgical Conditions Age Friendly Hospital Measure in IQR program Stop the Bleed program Cancer Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda National Trauma and Emergency Preparedness System (NTEPs) Administrative Burden/Prior Authorization Legislation Physician Burnout and Wellbeing Organ Transplant National Cancer Database (NCDB) updates Merit-based Incentive Payment System (MIPS) and MIPS Value Pathways (MVPs) Health Equity Firearm injury prevention research Global Code data collection Surgeon compensation studies Council on Graduate Medical Education (COGME) rural surgery studies Surgical Hospital Measures
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
Q4 Lobbying Report (Oct.1 -Dec. 31) HCR Transparency (surprise medical bills; public posting of hospital charges) 340B Drug Pricing Program Resident Physician Shortage Act of 2023 (H.R. 2389) No Surprises Act regulations Food and Drug Amendments No Surprise Bills for New Moms Act (H.R. 3387) Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544) Promoting Access to Treatments and Increasing Extremely Needed Transparency Act (H.R. 3561) Medicaid VBPs for Patients (MVP) Act (H.R. 2666) Providers and Payers COMPETE Act (H.R. 3284) To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program (H.R. 3290) Transparent PRICE Act (H.R. 3281/H.R. 2691)) Resident Physician Shortage Reduction (S. 1302) Medical Student Education Authorization Act (H.R. 3046) Save Americas Rural Hospitals Act (H.R. 833) Chronic Care Management Improvement Act (H.R. 2829) Safety From Violence for Healthcare Employees Act (H.R. 2584) Supporting Safety Net Hospitals Act (H.R. 2665) Patient Access to Higher Quality Health Care Act (H.R. 977/S.470) FEMA re: COVID-19 related reimbursement Public Health Guidance Transparency and Accountability Act of 2023 (H.R. 4529) Public Health Emergency Congressional Review Act (H.R. 4381) CDC Leadership Accountability Act of 2023 (H.R. 3813) Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421) Preparedness and Response Reauthorization Act (H.R. 4420) Childrens Hospital GME Support Reauthorization Act of 2023 (H.R. 3887) Health Care Price Transparency Act of 2023 (H.R. 4822) Providers and Payers COMPETE Act (H.R. 3284) Lower Costs, More Transparency Act (H.R. 5378 Transparency in Coverage Act (H.R. 4507) GOLD Card Act of 2023 (H.R. 4968) No Fees for EFTs Act (H.R.6487) Rural Health Care Facilities Revitalization Act (H.R. 5989) Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 7153) To amend title XVIII of the Social Security Act to establish a definition of essential health system in statute (H.R. 7397) Substance Use Disorder Workforce Act (H.R. 7050) 340B PATIENTS Act (H.R. 7635) The 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act (H.R. 8574) Improving Seniors Access to Timely Care Act (H.R. 8702/S.4532) The Preserving Emergency Access in Key Sites (PEAKS) Act (H.R. 7931) Rural Health Care Facilities Revitalization Act (H.R. 5989) MMM Accelerated and Advance Payment Program repayment flexibility Graduate Medical Education (GME) funding Telehealth flexibilities and payment Annual Prospective Payment System Rules Organ acquisition payment policies Californias Medicaid Hospital Quality Assurance Fee Program Medicare Advantage BUD FY 2025 Appropriations bills Nursing and allied health workforce funding FY 2025 budget request Further Continuing Appropriations and Other Extensions Act (H.R. 6363) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 5894) Tax Relief for American Families and Workers Act of 2024 (H.R. 7024) Extension of Continuing Appropriations and Other Matters Act, 2024 (H.R. 7463) Submitted Comments Regulatory Comment Letters SUBJECT: CMS-10913, Medicare Part C Utilization Management Annual Data Submission and Audit Protocol Data Request; Notice, Agency Information Collection Activities: Proposed Collection; Comment Request; Federal Register (Vol 89, No 145), September 10, 2024
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
2024 · fourth_quarter · Health Issues
HR 405 - Essential Medicines Strategic Stockpile Act of 2023 HR 3837 - Improving Public Health Preparedness Act HR 3557 - Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act S.2333/HR 4421 - Pandemic and All-Hazards Preparedness and Response Act HR 4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Client expense: $511,136 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · fourth_quarter · Health Issues
Good Samaritan Health Professionals Act (regarding ensuring access to care by protecting certain medical volunteers from lawsuits), H.R. 2819, entire bill; Pandemic and All-Hazards Preparedness and Response Act (regarding public health emergency and disaster response), S. 2333, no specific sections but possible amendments regarding liability protections for volunteer health professionals; Preparedness and Response Reauthorization Act (regarding public health preparedness and response), H.R. 4420, no specific sections but possible amendments regarding liability protections for volunteer health professionals; Preparing for All Hazards and Pathogens Reauthorization Act (regarding public health preparedness and response), H.R. 4421, no specific sections but possible amendments regarding liability protections for volunteer health professionals.
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
H.R.3046/S.1403 - Medical Student Education Authorization Act of 2023 Issue: Support grants for primary care training in medically under-resourced communities. Draft Social Determinants Accelerator Act Issue: Support grants to address social determinants of health. H.R.9161/S.4773 - Health Equity and Accountability Act of 2024 Issue: Support programs to improve health equity and address social determinants of health. S.2333 - Pandemic and All-Hazards Preparedness and Response Act H.R.4420 - Preparedness and Response Reauthorization Act H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act H.R.4697 - Protecting PAHPA Act of 2023 Issues: Support the reauthorization of the Pandemic and All-Hazards Preparedness Act with increased funding authorization levels. Issue: Support authorities to strengthen CDCs and ASPRs ability to prevent and respond to existing and emerging threats. S.1995 - Public Health Infrastructure Saves Lives Act Issue: Support investments in core public health infrastructure. Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers to fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program. Oppose efforts to reduce the scope of the program and transition 340B into a rebate model. H.R.2534 - Preserving Rules Ordered for the Entities Covered Through 340B Act of 2023 (PROTECT 340B Act) Issue: Support measures to prevent pharmacy benefit managers and commercial insurers from imposing discriminatory reimbursement policies on 340B covered entities. H.R.7635 - 340B Pharmaceutical Access to Invest in Essential, Needed Treatments and Support (340B PATIENTS) Act Issue: Support amending the 340B statute to codify covered entities ability to use contract pharmacies. H.R.3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. Issue: Oppose efforts to impose additional reporting requirements on 340B hospitals. Draft Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B (SUSTAIN 340B) Act Issue: Support efforts to prohibit pharmaceutical and pharmacy benefit manager (PBM) discrimination against covered entities. Oppose efforts to define patient in the context of the program. Oppose efforts to impose additional administrative and reporting requirements on 340B hospitals. H.R.8574 - 340B ACCESS Act Issue: Oppose efforts to restrict hospital eligibility for the 340B program. Issue: Oppose insurance plans that do not meet Affordable Care Act requirements. Issue: Support policies to improve maternal health outcomes through expanded Medicaid coverage, enhanced data collection, and improved access to behavioral health care during the perinatal period. P.L. 118-159 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 S.4638 National Defense Authorization Act for Fiscal Year 2025 Issue: Oppose prohibition on coverage for gender affirming care. H.R.2369 - Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 Issue: Educate Congress on development of laboratory developed tests (LDTs) at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing FDA regulation of the development of LDTs at academic medical centers. Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency. Issue: Provide guidance on the implementation of the No Surprises Act (P.L.116-260). Issue: Educate Congress and the administration on the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support policies to strengthen the behavioral health workforce, promote the uptake of integrated behavioral health models, advance mental health research, and ensure access to coverage and care. Issue: Educate Congress about the financial challenges facing academic medical centers, including reimbursement challenges, workforce challenges, inflation, and others. Issue: Educate Congress and the administration about the impact of the unwinding of the COVID-19 public health emergency on the academic medicine community and the patients they serve. H.R.3887 - Childrens Hospital GME Support Reauthorization Act of 2023 H.R.3841 - To amend title III of the Public Health Service Act to reauthorize the program of payments to children's hospitals that operate graduate medical education programs. Issue: Support clean reauthorization of the Childrens Hospital GME program. Issue: Support reauthorization of the National Health Service Corps and Teaching Health Center Graduate Medical Education. Issue: Express concern regarding actions to inappropriately undermine FDA regulatory authority. Issue: Educate Congress and the administration about medical education on nutrition, hunger, and health; reproductive health; substance use disorders; medication assisted treatment for opioid use disorders; trans health; preventing fraud and abuse; diversity, equity, and inclusion; menopause management; health care for people with disabilities; and maternal health. Issue: Educate Congress and the administration about resident physician practice decision making post US SCOTUS decision in Dobbs. Issue: Educate Congress on resident expectations related to clinical practice and oppose so-called physician service mandates. H.R.7855 - Rural Residency Planning and Development Act of 2024 Issue: Support codification of HRSAs rural residency planning and development program. Issue: Support providing discretionary funds for rural teaching hospitals to expand their residency programs. Issue: Educate Congress on vaccine safety. Issue: Encourage changes to HRSA financial aid programs as a result of FAFSA updates. Issue: Educate Congress on the use of artificial intelligence (AI) in academic medicine. S.4031 - Providing Resources and Opportunities for Health Education and Learning (PRO-HEAL) Act Issue: Support HRSA grants to expand provider pipeline programs to create pathways to health care careers. H.R.7258/S.3968 - Community Training, Education, and Access for Medical Education, and Access for Medical Students (TEAMS) Act Issue: Support enhanced community-based training opportunities for medical students, particularly in rural and medically underserved areas, and fostering long-term sustainable physician practices in high-need communities. H.R.7153/S.3673 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Issue: Support ability of HRSA to implement evidenced-based practices for preventing suicide and improving mental health and resiliency among health care professionals, and for training health care professionals in appropriate strategies to address substance use disorders. Issue: Provide input on Next Generation Cures initiative. Issue: Promote overdose prevention. H.R. 10047 The Closing the Substance Use Care Gap Act Issue: Support extension of SAMHSA harm reduction programs.
Client expense: $632,324 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Council on Disability, Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Vice President of the U.S., White House Office
2024 · fourth_quarter · Health Issues
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Labor Issues/Antitrust/Workplace
Lobbied to raise the profile of the severe shortage of paramedics and emergency medical technicians (EMTs) and address the problem through emergency medical service training programs for emergency medical service professional and retain current paramedics and EMTs through access to first responder benefits. Lobbied on the PARA-EMT Act (H.R.6433), Pathways to Health Careers Act (H.R. 4783, S. 3449), Supporting our First Responders Act (H.R. 1737), Homes for Every Local Protector, Educator, and Responder Act (H.R. 3170, S. 1514), National Apprenticeship Act (S. 2122, H.R. 2851), Apprenticeship Pathways Act (S. 2124), Freedom to Invest in Tomorrow's Workforce Act (S. 722, H.R. 1477), Bipartisan Primary Care and Health Workforce Act (S. 2840), legislation on the Reauthorization of the Pandemic and All-Hazards Preparedness Act (S. 2333, H.R. 4421) and the 2025 National Defense Reauthorization Act (H.R. 8070).
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Health Issues
Infectious diseases (generally, no specific legislation); antimicrobial (generally, no specific legislation); hospital-acquired infections (generally, no specific legislation); immunizations (generally, no specific legislation); pandemic influenza (generally, no specific legislation); public health security and bio-defense (generally, no specific legislation); global infectious diseases (generally, no specific legislation); biomedical research (generally, no specific legislation); President's Emergency Plan for AIDS Relief (PEPFAR) (generally, no specific legislation); Lyme diseases and other infectious diseases issues (generally, no specific legislation); Ryan White Care Act (generally, no specific legislation); Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR);HIV Epidemic Loan Repayment Program (HELP) Act(H.R. 2295) Verifying Accurate Leading Edge IVCT Development (VALID Act HR 3128/S.2209), Infectious diseases and bio-preparedness health professionals loan repayment issues, BIO Preparedness Workforce Act (S.3244/H.R.5602), Monkeypox outbreak and response (generally, no specific information), PHE Outbreak Activation Act (not-yet introduced), PREVENT Pandemics Act, Preparing for All Hazards and Pathogens Reauthorization Act (HR 4421), Pandemics and All-Hazards Preparedness and Response Act (S.2333), ID incentive payments (no specific information or bill numbers), CMS Medicare Physician Fee Schedule
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2024 · third_quarter · Health Issues
Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals including Strategic National Stockpile appropriations and reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act; S.2624/HR 5894, the Fiscal Year 2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; the Fiscal Year 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Health Issues
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 456: Fairness in Orphan Drug Exclusivity Act H.R. 830: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1613: Drug Price Transparency in Medicaid Act of 2023 H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2534: PROTECT 340B Act of 2023 - Provisions related to the 340B program H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 2707: MADE in America Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3433: Give Kids a Chance Act of 2024 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3839: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act H.R. 4895: Lowering Drug Costs for American Families Act - Provisions related to drug pricing H.R. 4988: Modern Authentication of Pharmaceuticals Act of 2023 H.R. 5376: Share the Savings with Seniors Act H.R. 5378: Lower Costs, More Transparency Act H.R. 5391: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 5539: ORPHAN Cures Act H.R. 6283: Delinking Revenue from Unfair Gouging or DRUG Act H.R. 6664: Innovation in Pediatric Drugs Act of 2023 H.R. 7174: Ensuring Pathways to Innovative Cures (EPIC) Act: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7248: FDA Modernization Act 3.0 H.R. 7623: Telehealth Modernization Act of 2024 H.R. 7635: The 340B PATIENTS Act of 2024 H.R. 8574: 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act H.R. 9096: Pharmacists Fight Back Act S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1130: Health Care PRICE Transparency Act S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 1589: Safeguarding Patients and Taxpayers Act S. 1906: Promising Pathway Act - Approval pathway policy issues S. 1967: PBM Act S. 2305: Biosimilar Red Tape Elimination Act S. 2333: Pandemic and All-Hazards Preparedness and Response Act S. 2474: Share the Savings with Seniors Act S. 2973: Modernizing and Ensuring PBM Accountability Act (MEPA) S. 3393: SUPPORT for Patients and Communities Reauthorization Act S. 5021: The 340B PATIENTS Act of 2024 BioCompete Act (draft) Executive Order of February 28, 2024, Preventing Access to Americans' Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) User fee policy issues Health Equity Inflation Reduction Act of 2022 (P.L. 117-169), Implementation IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Pandemic preparedness policy issues Cybersecurity policy issues Artificial intelligence policy issues
Client expense: $1,540,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2024 · third_quarter · Health Issues
H.R. 4527 Health DATA Act S. 3679, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 5378 the Lower Costs, More Transparency Act S.3548 - Health Care Prices Revealed and Information to Consumers Explained Transparency Act S.3430 - An original bill to amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes. HR 3305 & S. 1606 Black Maternal Health Momnibus Act HR 4822 Health Care Price Transparency Act HR 3284 Providers and Payers COMPETE Act HR 2840 Bipartisan Primary Care and Health Workforce Act HR 4818 Treat and Reduce Obesity Act of 2023 S. 2333 Pandemic and All Hazards Preparedness and Response Act H.R. 4421 Preparing for All Hazards and Pathogens Reauthorization Act H.R. 3561, PATIENT Act of 2023 H.R. 3281, the Transparent PRICE Act H.R. 3262, To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R. 2868 Association Health Plans Act H.R. 2813 Self-Insurance Protection Act H.R. 3799 CHOICE Arrangement Act H.R. 3432, Telemental Health Care Access Act H.R.824, Telehealth Benefit Expansion for Workers Act of 2023 H.R. 4189, S. 2016, CONNECT for Health Act S. 923, Better Mental Health Care for Americans Act H.R. 3120, Healthy Competition for Better Care Act H.R. 1843 Telehealth Expansion Act of 2023 Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage, the transition out of the COVID-19 pandemic and electronic health information/technology. S.954 - 118th Congress (2023-2024)A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals. a
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Health Issues
National Defense Authorization Act for 2024, H.R. 2670 Pandemic and All-Hazards Preparedness and Response Act, S. 2333 Preparing for All Hazards and Pathogens Reauthorization Act, H.R. 4421 Further Consolidated Appropriations Act, 2024, H.R. 2882 Other issues related to the Strategic National Stockpile, Biodefense, Preparedness, Biomanufacturing
Client expense: $130,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE
2024 · third_quarter · Defense
National Defense Authorization Act for 2024, H.R. 2670 Pandemic and All-Hazards Preparedness and Response Act, S. 2333 Preparing for All Hazards and Pathogens Reauthorization Act, H.R. 4421 Further Consolidated Appropriations Act, 2024, H.R. 2882 Other issues related to the Strategic National Stockpile, Biodefense, Preparedness, Biomanufacturing
Client expense: $130,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE
2024 · third_quarter · Health Issues
Issues relating to drug pricing, home dialysis expansion, ESRD reimbursement for Hemodialysis, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic preparedness act. H. Res. 550 and H.R. 4421. Issues related to artificial intelligence technology in healthcare.
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to dialysis. Issues regarding the pharmaceutical supply chain. Issues concerning drug shortages. Monitored issues concerning sterilization of medical devices. S. 2333, Pandemic and All-Hazards Preparedness and Response Act (PAHPA). H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. Issues related to drug shortages.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Monitored S. 2333, Pandemic and All-Hazards Preparedness and Response Act regarding PAHPA reauthorization. Monitored H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act. S. 2840, Bipartisan Primary Care and Health Workforce Act, as it relates to hospitals and the healthcare workforce. Issues involving workforce shortages. Issues related to mental health. Monitored issues related to the World Trade Center Health Program. Monitored issues regarding ARPA-H. Issues involving drug shortages. Issues regarding NIH reform. Issues concerning Hurricane Helene.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 456: Fairness in Orphan Drug Exclusivity Act H.R. 830: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1613: Drug Price Transparency in Medicaid Act of 2023 H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2534: PROTECT 340B Act of 2023 - Provisions related to the 340B program H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 2707: MADE in America Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3433: Give Kids a Chance Act of 2024 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3839: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act H.R. 4818: Treat and Reduce Obesity Act of 2023 H.R. 4895: Lowering Drug Costs for American Families Act - Provisions related to drug pricing H.R. 4988: Modern Authentication of Pharmaceuticals Act of 2023 H.R. 5376: Share the Savings with Seniors Act H.R. 5378: Lower Costs, More Transparency Act H.R. 5391: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 5539: ORPHAN Cures Act H.R. 6283: Delinking Revenue from Unfair Gouging or DRUG Act H.R. 6664: Innovation in Pediatric Drugs Act of 2023 H.R. 7174: Ensuring Pathways to Innovative Cures (EPIC) Act: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7248: FDA Modernization Act 3.0 H.R. 7623: Telehealth Modernization Act of 2024 H.R. 7635: The 340B PATIENTS Act of 2024 H.R. 8574: 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act H.R. 9096: Pharmacists Fight Back Act S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1130: Health Care PRICE Transparency Act S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1497: Emergency Access to Insulin Act of 2023 S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 1589: Safeguarding Patients and Taxpayers Act S. 1906: Promising Pathway Act - Approval pathway policy issues S. 1967: PBM Act S. 2305: Biosimilar Red Tape Elimination Act S. 2333: Pandemic and All-Hazards Preparedness and Response Act S. 2474: Share the Savings with Seniors Act S. 2973: Modernizing and Ensuring PBM Accountability Act (MEPA) S. 3393: SUPPORT for Patients and Communities Reauthorization Act S. 5021: 340B PATIENTS Act of 2024 BioCompete Act (draft) Executive Order of February 28, 2024, Preventing Access to Americans' Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) User fee policy issues Inflation Reduction Act of 2022 (P.L. 117-169) IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Compounding policy issues Antimicrobial resistance (AMR) policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Pandemic preparedness policy issues Artificial intelligence policy issues Cybersecurity policy issues
Client expense: $6,880,000 · Firm income: Not reported
Government targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of